Results 201 to 210 of about 3,895,310 (341)

Catheter-directed thrombolysis of deep vein thrombosis: literature review and practice considerations.

Cardiovascular Diagnosis and Therapy, 2017
D. Fleck, H. Albadawi, F. Shamoun, G. Knuttinen, S. Naidu, R. Oklu   +5 more
semanticscholar   +1 more source

siRNA Delivery via Cross‐Linked Gelatin Microparticles Enables Targeted Modulation of Osteogenic‐Vascular Cross‐Talk: An Advanced Human 3D in Vitro Test System for Therapeutic siRNA

Advanced Healthcare Materials, EarlyView.
Osteogenic‐angiogenic cross‐talk is a vital prerequisite for vascularized bone regeneration. In this study, we investigated the effects of siRNA‐mediated silencing of two inhibitory proteins, Chordin and WWP‐1, via CaP‐NP‐loaded gelatin microparticles in osteogenically differentiated microtissues.
Franziska Mitrach, Jonas Kubat, Stefan Simm, Alexandra H. Springwald, Burak Demir, Anton Liebezeit, Michael C. Hacker, Michaela Schulz‐Siegmund   +7 more
wiley   +1 more source

Dramatic response to low-dose rivaroxaban in an Asian patient with deep vein thrombosis and pulmonary embolism [PDF]

, 2013
Junji Yamaguchi, Kunihiko Makino, Yukiko Kusunose, Shirika Higa, Takuro Takagi, Ken Suzuki, Tetsuo Lee   +6 more
openalex   +1 more source

Extensive Collateral Venous Circulation and Anatomic Remodeling in Chronic Deep Vein Thrombosis. [PDF]

Case Rep Cardiol
Curbelo D, Lancaster I, Yaylayan A, Krolick M.   +3 more
europepmc   +1 more source

Engineered ETS1‐Nanoconjugate Restores Immune Homeostasis through Dual Immune‐Vascular Modulation in Relapsing and Progressive Multiple Sclerosis

Advanced Healthcare Materials, EarlyView.
The biomimetic nanoplatform IMNP (ETS1 pDNA/PBAE@ITP‐MM) undergoes targeted disassembly at inflammatory vascular sites to release the ETS1 plasmid (pETS1). This release initiates a cascade of effects that inhibit pathogenic pathways and support immune homeostasis. (Abbreviations: EndMT, endothelial‐to‐mesenchymal transition; EC, endothelial cell; TC, T
Feng Zhang, Si‐Bo Yang, Yan Luo, Xiao‐Di Sun, Bo‐Hao Chang, Da‐Qiang Zhou, Jun‐Jie Jiang, Ya‐Nan Li, Jie‐Hong Wu, Hui‐Juan Jin, Hang Yang, Hang Hu, Yi‐Fan Zhou, Bo Hu   +13 more
wiley   +1 more source

Trends in mortality from deep vein thrombosis and pulmonary embolism as multiple causes of death in u.S. adults aged ≥65 years (1999–2023): A CDC wonder analysis [PDF]

Hakim Wazir, Awais Amjad, Krishna Shah, Nayanika Tummala, Shalin Rawal, Adnan Sharif, Arun Chauhan, Minahil Zaheer, Abdul Majid, Shaheen Nawaz, Noora Inam, Vedant Shah, Bolivia Fernandes, Nirmit Patel, Love Kumar   +14 more
openalex   +1 more source

Reply to: Modeling concomitant pulmonary embolism in patients with deep vein thrombosis: Can we do better? [PDF]

J Vasc Surg Venous Lymphat Disord
Gong M, He X, Gu J.
europepmc   +1 more source

Ferritin‐Doped Nanoparticles Triggered Tumor‐Specific Darkening for Enhanced Photothermal Tumor Ablation and Immune Activation

Advanced Healthcare Materials, EarlyView.
Ferritin‐doped hybrid nanoparticles triggered accurate tumor‐specific hemorrhage for enhanced in situ photothermal therapy and evoked anti‐tumor immunity. Notably, HFn/GA‐Fe specifically induced tumor hemorrhage 12 h after intravenous injection, resulting in visible color darkening. Through photoacoustic imaging, tumor vessels could be clearly observed
Haidong Zha, Xiao Liang, Long Xi, Jiamao Chen, Wenzhao Zhong, Zhen Yuan, Meng Xu, Ying Zheng   +7 more
wiley   +1 more source

NAT10-Mediated ac4C-Modification Exacerbates Ferroptosis by Stabilizing HMOX1 in Deep Vein Thrombosis. [PDF]

Arterioscler Thromb Vasc Biol
Zhang Y, Zhang Z, Liu X, Chu C, Yu X, Han Q, Li W, Zhang T, Zu H, Fan N, Wei R, Shi F, Li F, Xu F, Wang B, Li X.   +15 more
europepmc   +1 more source

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study.

Archives of Internal Medicine, 2000
J. Heit, Marc D. Silverstein, Marc D. Silverstein, D. Mohr, T. Petterson, W. O'Fallon, L. J. Melton   +6 more
semanticscholar   +1 more source